Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G17DT in Gastric Cancer
NCT02521649Phase 2Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Sep 1998
- Primary completion
- Jan 2001
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of G17DT immunogen in gastric cancer (GC), sponsored by Cancer Advances, Inc.. Started Sep 1998; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02521649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02521649.